In SCALE, Victoza produced about 8% average body-weight loss over 56 weeks. Appetite typically drops within 1–2 weeks, with visible weight loss starting around 4–8 weeks; individual results vary widely and are best maintained with long-term use.
Victoza weight-loss results
Victoza produced 8% mean body-weight reduction in the SCALE pivotal trial at 56 weeks — substantially more than placebo. This page details the clinical evidence, eligibility criteria, and what individual results look like in practice.
How effective is Victoza?
Mean body-weight change at 56 weeks in the SCALE trial. Source: FDA prescribing information.
Vs placebo
+5.4 pts
Moderate signal
Vs GLP-1 class ceiling
36% of ceiling
Mid-range GLP-1
Individual results vary. Trial participants also received lifestyle counseling. Full disclaimer.
Expected weight-loss curve
Mean body-weight change across 56 weeks on Victoza from the SCALE trial. Curve smoothed from published endpoints; individual results vary significantly.
Trial participants also received lifestyle counseling. Real-world results depend on dose adherence, side-effect tolerance, and lifestyle factors.
Eligibility criteria
Who Victoza is for — and not for
3 typical-fit criteria · 5 disqualifying conditions. Quick-screen yourself, then confirm with a licensed prescriber.
Often a fit for
- Adults with type 2 diabetes (Victoza)
- Adults with BMI ≥30, or ≥27 with weight-related condition (Saxenda)
- Patients who prefer daily dosing schedule
Not appropriate if
- Personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2
- Pregnancy or planning pregnancy
- Type 1 diabetes
- History of pancreatitis
Eligibility is determined by a licensed prescriber, not GLP1Zoom. See our medical disclaimer.
What individual results actually look like
Trial averages obscure huge individual variation. The 8% figure from SCALE is a mean: within the same trial some participants lost far more, a minority lost little or nothing, and response was not predictable in advance from baseline characteristics alone. Read the average as the middle of a wide spread, not as a target you should expect to hit.
Predictors of better response include: starting BMI ≥ 35, adherence to dose schedule, concurrent lifestyle changes (reduced caloric intake, regular activity), and patient commitment to long-term treatment. Predictors of worse response include: dose reductions from side effects, sporadic adherence, and certain genetic variations under research.
Timing — when results show up
Early appetite reduction begins within 1-2 weeks of starting Victoza. Visible weight loss usually starts at 4-8 weeks after reaching the second titration dose. Maximum effect plateaus around the trial endpoint timing (typically 56-72 weeks depending on the medication). Without continued treatment, regain occurs gradually — most patients regain 2/3 of lost weight within 1 year of stopping.
Victoza vs other weight-loss approaches
Compared to other options:
- vs lifestyle alone (diet+exercise): typical lifestyle programs produce 3-8% weight loss. Victoza produced 8% in SCALE — several times more.
- vs older weight-loss medications (phentermine, orlistat): produce ~5-7%, so the trial figure above is substantially higher.
- vs bariatric surgery: surgery typically produces 25-35% weight loss and is permanent, versus 8% on the medication with weight regain likely after stopping. Surgery is more effective but irreversible.
Side effects affecting weight-loss outcomes
Side effects affect how much weight a patient actually loses:
- Patients who reach the target dose with manageable side effects achieve maximum benefit
- Patients who must stay at a lower-than-target dose (due to intolerable side effects) typically lose less weight
- Patients who discontinue early due to side effects often regain rapidly
See our Victoza side effects guide for management tactics that improve adherence.
Long-term outlook — what happens after a year?
Most clinical data for Victoza covers 56-72 weeks. Longer-term safety and effectiveness data is accumulating. Key questions still being answered: Is the weight loss maintained at 2-5 years? Are there long-term safety signals not visible in 18-month trials? What happens to insulin sensitivity, cardiovascular events, and other outcomes long-term? Current guidance: treat Victoza as a long-term medication (years), not a short course.
FAQ about Victoza for weight loss
How fast does Victoza work for weight loss?
Many people notice reduced appetite within the first few weeks, and more visible weight loss typically develops over the first one to two months. In the clinical trials that studied this medication’s active ingredient, weight loss generally continued for up to about 56 weeks before leveling off. Individual results vary, and this is general information, not medical advice — talk with your prescriber about what to expect for you.
Will I regain weight if I stop Victoza?
Most patients regain a large share of lost weight within about a year of stopping, based on extension studies. This is why Victoza is typically treated as a long-term medication rather than a short course. Discuss any stop or pause with your prescriber.
What if Victoza doesn’t produce enough weight loss for me?
A minority of patients are low responders (less than 5% weight loss at the full maintenance dose). Options your prescriber may discuss include switching to a different medication in this class — for example, in head-to-head trials tirzepatide (a dual GIP/GLP-1 medication) produced more weight loss on average than semaglutide, if you are not already taking it — adding an adjunct therapy, or evaluating whether you may be a candidate for bariatric surgery. Any change should be decided with your prescriber. See our alternatives guide for a comparison.
See also: Victoza alternatives. Editorial summary based on FDA-approved trial data. Individual results vary. Full disclaimer.